Gabriel Lai, Ph.D.
Program Director, Environmental Epidemiology Branch

Gabriel Lai

Address:
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E126, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)

Interest Areas

  • Modifiable and lifestyle factors—such as diet and nutrition, obesity, diabetes, and energy metabolism—related to cancer risk and etiology and other cancer-related outcomes
  • Cancer disparities in racial/ethnic groups in the United States and other countries; global health
  • Early-life exposures

Degrees

  • Ph.D. - Epidemiology
    Johns Hopkins University, Bloomberg School of Public Health
  • M.H.S. – Epidemiology
    Johns Hopkins University, Bloomberg School of Public Health
  • B.A. - Psychology and Molecular and Cell Biology, University of California, Berkeley

Biography

Dr. Gabriel Lai is a Program Director in the Environmental Epidemiology Branch (EEB)—formerly the Modifiable Risk Factors Branch (MRFB)—of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). His responsibilities include managing a research portfolio that focuses on modifiable and lifestyle risk factors, including nutrition, obesity, and environmental exposures. He also is involved in cohort- and consortia-related activities such as the NCI Cohort Consortium.

Before joining EGRP in 2013, Dr. Lai was a Cancer Prevention Fellow in the Nutritional Epidemiology Branch in NCI's intramural Division of Cancer Epidemiology and Genetics. In this position, he developed and conducted research to evaluate diet and energy metabolism in liver and other cancers in large U.S. and international cohort studies. He received the NIH Fellows Award for Research Excellence in 2011 and 2012 for this work.

Publications

Lai GY, Weinstein SJ, Taylor PR, McGlynn KA, Virtamo J, Albanes D, Gail MH, Freedman ND. Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC StudyExternal Web Site Policy. Br J Cancer. 2014 Dec 9;111(12):2220-3.

Murphy G, Michel A, Taylor PR, Albanes D, Weinstein SJ, Virtamo J, Parisi D, Snyder K, Butt J, McGlynn KA, Koshiol J, Pawlita M, Lai GY, Abnet CC, Dawsey SM, Freedman ND. Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC studyExternal Web Site Policy. Hepatology. 2014 Dec;60(6):1963-71.

Faupel-Badger JM, McElrath TF, Lauria M, Houghton LC, Lim K, Parry S, Cantonwine D, Lai G, Karumanchi SA, Hoover RN, Troisi R. Maternal circulating angiogenic factors in twin and singleton pregnanciesExternal Web Site Policy. Am J Obstet Gynecol. 2014 Nov 27. pii:S0002-9378(14)02359-X.

Lai GY, Weinstein SJ, Albanes D, Taylor PR, Virtamo J, McGlynn KA, Freedman ND. Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortalityExternal Web Site Policy. Br J Cancer. 2014 Nov 25;111(11):2163-71.

Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA. Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up StudyExternal Web Site Policy. Cancer Causes Control. 2014 May;25(5):625-32.

Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, Sinha R, Freedman ND. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokersExternal Web Site Policy. Br J Cancer. 2013 Sep 3;109(5):1344-51.

Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND. The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health StudyExternal Web Site Policy. J Clin Endocrinol Metab. 2013 Mar;98(3):E497-502.

Return to Top